Որոնման արդյունքները - Xiaomin Wan
- Ցուցադրվում են 1 - 4 արդյունքները 4
-
1
First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: A United States–based cost‐effectiveness analysis... Xiaomin Wan, Xia Luo, Chongqing Tan, Xiaohui Zeng, Yucong Zhang, Liubao Peng
Հրապարակվել է 2019Artigo -
2
Overexpression of Mitochondrial Phosphate Transporter 3 Severely Hampers Plant Development through Regulating Mitochondrial Function in Arabidopsis Fengjuan Jia, Xiaomin Wan, Wei Zhu, Dan Sun, Chengchao Zheng, Pei Liu, Jinguang Huang
Հրապարակվել է 2015Artigo -
3
-
4
Cost-Effectiveness of First-Line Versus Second-Line Pembrolizumab or Chemotherapy in Patients With Microsatellite-Instability-High/Mismatch Repair-Deficient Advanced Colorectal Can... Chongqing, Tan, Sini, Li, Xiaohui, Zeng, Liubao, Peng, Ye, Peng, Shuxia, Qin, Liting, Wang, Meiyu, Wu, Xiaomin, Wan
Հրապարակվել է 2021Տեքստ
Որոնման գործիքներ:
Առնչվող խորագիր
Cancer
Immunotherapy
Internal medicine
Lung cancer
Medicine
Oncology
Alternative oxidase
Arabidopsis
Arabidopsis thaliana
Atezolizumab
Bevacizumab
Biochemistry
Biology
Carboplatin
Cell biology
Cellular respiration
Chemotherapy
Cisplatin
Cost effectiveness
Cytosol
Docetaxel
Enzyme
Gene
Intensive care medicine
Mitochondrion
Mutant
Nivolumab
Organelle
Paclitaxel
Pembrolizumab